These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17489837)

  • 1. Case management in children affected by non-alcoholic fatty liver disease.
    Nobili V; Manco M; Raponi M; Marcellini M
    J Paediatr Child Health; 2007 May; 43(5):414. PubMed ID: 17489837
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.
    Preiss D; Sattar N
    Clin Sci (Lond); 2008 Sep; 115(5):141-50. PubMed ID: 18662168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic steatohepatitis in children.
    Roberts EA
    Clin Liver Dis; 2007 Feb; 11(1):155-72, x. PubMed ID: 17544977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease in children.
    Cheung CR; Kelly DA
    BMJ; 2011 Jul; 343():d4460. PubMed ID: 21768193
    [No Abstract]   [Full Text] [Related]  

  • 5. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
    Rafiq N; Younossi ZM
    Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutics of non-alcoholic fatty liver disease].
    Wong VW; Fan JG; Chan HL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):687-8. PubMed ID: 17903373
    [No Abstract]   [Full Text] [Related]  

  • 8. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
    Oh MK; Winn J; Poordad F
    Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S; Muratore C; Craxì A
    Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.
    Barshop NJ; Sirlin CB; Schwimmer JB; Lavine JE
    Aliment Pharmacol Ther; 2008 Jul; 28(1):13-24. PubMed ID: 18397387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease.
    Björnsson E; Angulo P
    Scand J Gastroenterol; 2007 Sep; 42(9):1023-30. PubMed ID: 17710666
    [No Abstract]   [Full Text] [Related]  

  • 13. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.
    Manco M; Bedogni G; Marcellini M; Devito R; Ciampalini P; Sartorelli MR; Comparcola D; Piemonte F; Nobili V
    Gut; 2008 Sep; 57(9):1283-7. PubMed ID: 18218674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of non-alcoholic steatohepatitis: human data.
    Edmison J; McCullough AJ
    Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are children after liver transplant more prone to non-alcoholic fatty liver disease?
    Nobili V; Dhawan A
    Pediatr Transplant; 2008 Sep; 12(6):611-3. PubMed ID: 18346037
    [No Abstract]   [Full Text] [Related]  

  • 16. Nutrition and metabolism: non-alcoholic fatty liver disease - pathogenesis, cardiovascular risk and therapy.
    Watts GF; Gan SK
    Curr Opin Lipidol; 2008 Feb; 19(1):92-4. PubMed ID: 18196992
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease: the mist gradually clears.
    de Alwis NM; Day CP
    J Hepatol; 2008; 48 Suppl 1():S104-12. PubMed ID: 18304679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease.
    Baranova A; Liotta L; Petricoin E; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):209-20, xi. PubMed ID: 17544980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical aspects of non-alcoholic fatty liver disease.
    Björnsson E
    Minerva Gastroenterol Dietol; 2008 Mar; 54(1):7-18. PubMed ID: 18299664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.